A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/01/2011	US20110294901 Finely pulverized pharmaceutical composition
12/01/2011	US20110294900 Self emulsifying drug delivery system for a curcuminoid based composition
12/01/2011	US20110294898 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol Hydrochloride
12/01/2011	US20110294897 Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion
12/01/2011	US20110294896 Topical Treatment With Dapsone In G6PD-Deficient Patients
12/01/2011	US20110294895 Bis(thio-hydrazide amide) formulation
12/01/2011	US20110294894 Pharmaceutical Composition for the Treatment of Solar Urticaria
12/01/2011	US20110294893 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
12/01/2011	US20110294892 Use of histone deacetylase inhibitors for the care of Philadephia-negative myeloproliferative syndromes
12/01/2011	US20110294891 Methods and compositions for treating opthalmic conditions with retinol derivatives
12/01/2011	US20110294890 Neramexane for the treatment or prevention of inner ear disorders
12/01/2011	US20110294889 Infusion and Injection Solution of Levodopa
12/01/2011	US20110294887 Controlled-release solution formulations of pregabalin
12/01/2011	US20110294886 Controlled-release tablet formulations of pregabalin
12/01/2011	US20110294885 Controlled-release pregabalin compositions
12/01/2011	US20110294884 Bipolar trans carotenoid salts and their uses
12/01/2011	US20110294883 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
12/01/2011	US20110294882 Novel derivatives of 3,3-diphenylpropylamines
12/01/2011	US20110294881 METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING alpha2delta SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
12/01/2011	US20110294880 Pharmaceutical composition containing prostaglandin
12/01/2011	US20110294879 Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
12/01/2011	US20110294878 Inhibitors of Dimethylarginine Dimethylaminohydrolase
12/01/2011	US20110294877 Transition metal complexes of bis[thiohydrazide amide] compounds
12/01/2011	US20110294876 Cyclohexyl carbamate compounds as anti-ageing actives
12/01/2011	US20110294875 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/01/2011	US20110294874 Diagnosis and therapy of organ dysfunction using sphinganine-1-phosphate
12/01/2011	US20110294872 High-affinity nucleic acid aptamers against sclerostin protein
12/01/2011	US20110294871 Lipids, lipid complexes and use thereof
12/01/2011	US20110294870 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
12/01/2011	US20110294869 Self delivering bio-labile phosphate protected pro-oligos for oligonucleotide based therapeutics and mediating rna interference
12/01/2011	US20110294868 Modulation of transthyretin expression
12/01/2011	US20110294867 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
12/01/2011	US20110294866 Pharmaceutical composition for treating dementia comprising shrna inhibiting s100a9 expression
12/01/2011	US20110294865 Methods of detecting a fragment of neurosecretory protein vgf for diagnosing alzheimer's disease
12/01/2011	US20110294864 Aqueous coacervate compositions suitable for making powders and water-soluble formulations of biologically-active agents
12/01/2011	US20110294862 Treatment or prevention of hypotension and shock
12/01/2011	US20110294861 Method of treatment of hereditary hemochromatosis
12/01/2011	US20110294860 Aqueous oral preparation of stable amlodipine
12/01/2011	US20110294859 Substituted pyridoxine-lactam carboxylate salts
12/01/2011	US20110294858 Substituted 6-methylnicotinamides as mglur5 positive allosteric modulators
12/01/2011	US20110294857 Inhibitor of casein kinase 1delta and casein kinase 1epsilon
12/01/2011	US20110294856 Novel oxadiazole derivatives and their medical use
12/01/2011	US20110294854 SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS
12/01/2011	US20110294853 Bis Aromatic Compounds for Use in the Treatment of Inflammation
12/01/2011	US20110294852 Pharmaceutical Formulation Comprising Metformin and Repaglinide
12/01/2011	US20110294851 Amidine-containing compounds useful as muscarinic receptor antagonists
12/01/2011	US20110294850 Indoline derivatives
12/01/2011	US20110294849 Aminopyrazole triazolothiadiazole inhibitor of c-met protein kinase
12/01/2011	US20110294848 Small molecule inhibitors of botulinum neurotoxins
12/01/2011	US20110294847 Novel Polymorphs Of Azabicyclohexane
12/01/2011	US20110294846 Indole derivatives as anticancer agents
12/01/2011	US20110294845 Parenteral formulations
12/01/2011	US20110294844 9-aminonoscapine and its use in treating cancers, including drug-resistant cancers
12/01/2011	US20110294843 Administration scheme of polar opioid metabolites for post-operative pain management
12/01/2011	US20110294842 Spiro (furo [3, 2-c] pyridine-3-3' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain
12/01/2011	US20110294841 Novel statin pharmaceutical compositions and related methods of treatment
12/01/2011	US20110294839 Novel polymorphs of lopinavir
12/01/2011	US20110294838 Sulfoximine-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as medicine
12/01/2011	US20110294837 Aurora Kinase Modulators and Methods of Use
12/01/2011	US20110294836 Aryl gpr119 agonists and uses thereof
12/01/2011	US20110294835 Muscarinic Agonists as Cognitive Enhancers
12/01/2011	US20110294834 Alkyl-substituted pyrazolopyrimidines
12/01/2011	US20110294833 Methods for Healthy Aging
12/01/2011	US20110294832 Fused ring compound and use thereof
12/01/2011	US20110294831 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt
12/01/2011	US20110294828 Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative
12/01/2011	US20110294827 Iap binding compounds
12/01/2011	US20110294826 Pyrrolo[2,3-d]pyrimidine compounds
12/01/2011	US20110294825 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294824 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
12/01/2011	US20110294823 Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperzaine compounds
12/01/2011	US20110294822 Substituted Phenylpiperazinyl Aralkylalcohol Derivatives, Pharmaceutical Compositions Containing Such Derivatives and Uses Thereof
12/01/2011	US20110294821 5-ht1a receptor subtype agonist
12/01/2011	US20110294820 N-Oxides of n-Phenyl-2-pyrimidine-amine Derivatives
12/01/2011	US20110294819 Hepatitis C Virus Inhibitors
12/01/2011	US20110294818 1h-quinazoline-2,4-diones
12/01/2011	US20110294817 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine d3 receptor
12/01/2011	US20110294816 Pyrrolotriazine kinase inhibitors
12/01/2011	US20110294815 Prostacyclin analogs
12/01/2011	US20110294814 Compounds for treating proliferative disorders
12/01/2011	US20110294813 Oxazolidinone derivative having inhibitory activity on 11beta-hydroxysteroid dehydrogenase type 1
12/01/2011	US20110294812 P38 map kinase inhibitors
12/01/2011	US20110294811 Abt-263 crystalline forms
12/01/2011	US20110294809 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
12/01/2011	US20110294808 Indazole Compounds As CCR1 Receptor Antagonists
12/01/2011	US20110294807 Compounds for the prevention and treatment of cardiovascular disease
12/01/2011	US20110294806 Azaindole derivatives as kinase inhibitors
12/01/2011	US20110294805 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators and methods of use thereof
12/01/2011	US20110294804 Novel bicyclic heterocyclic compound
12/01/2011	US20110294803 Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders
12/01/2011	US20110294802 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2011	US20110294801 Macrocyclics pyrimidines as aurora kinase inhibitors
12/01/2011	US20110294800 Hypoglycemic dihydropyridones
12/01/2011	US20110294799 Organic Compounds
12/01/2011	US20110294798 Il-12 modulatory compounds
12/01/2011	US20110294797 Reverse-turn mimetics and method relating thereto
12/01/2011	US20110294796 Benzotriazine inhibitors of kinases
12/01/2011	US20110294795 Methods of synthesis and/or purification of diaminophenothiazinium compounds
12/01/2011	US20110294794 Treatment of proteinopathies using a farnesyl transferase inhibitor
12/01/2011	US20110294793 Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors

1 ... 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 ... 7860